The global market for Long-acting Depot System was valued at US$ 47154 million in the year 2024 and is projected to reach a revised size of US$ 61195 million by 2031, growing at a CAGR of 3.9% during the forecast period.

Long-acting Depot System Market

The Long-acting Depot System refers to an advanced drug delivery technology designed to control the release rate of drugs, extend therapeutic duration, and reduce dosing frequency. Typically utilizing biodegradable polymers (such as PLGA) or lipid carriers, this system enables sustained drug release in the form of injectables, implants, or microspheres over weeks or even months. It is widely applied in treating chronic conditions such as psychiatric disorders, cancer, diabetes, and contraception, enhancing patient adherence and therapeutic consistency. With the advancement of precision medicine, biologics, and controlled-release materials, long-acting depot systems have become a critical frontier in pharmaceutical innovation.

The rapid growth of the long-acting depot system market is primarily driven by the increasing prevalence of chronic diseases, the demand for improved medication adherence, and the expanding use of long-acting formulations in biologics. Pharmaceutical companies are actively developing injectable and implantable drug delivery platforms to enhance product differentiation. Furthermore, advancements in polymer science and nanotechnology are enabling better control of drug stability and release kinetics, broadening the system’s applications in oncology, hormone therapy, and mental health management.

Despite its promising potential, the market faces technical barriers such as high manufacturing complexity, elevated raw material costs, and challenges in maintaining precise control over drug release. Compatibility issues between drugs and carriers, injection site reactions, and stringent regulatory approval processes hinder rapid commercialization. Moreover, ensuring the stability and storage conditions of biologics requires advanced formulation design, extending R&D timelines and increasing production risks.

Key growth segments include psychiatry, endocrinology, oncology, and women’s health. The growing patient preference for fewer administrations with sustained efficacy is driving a shift from oral or short-acting injections toward long-acting formulations. Pharmaceutical companies and healthcare providers are increasingly adopting depot-based personalized treatment models to improve adherence and cost efficiency. Integration with digital health platforms is also expanding the role of depot systems in telemedicine and home-based care.

The upstream segment primarily consists of biodegradable polymers (such as PLGA, PLA, and PCL), lipid materials, release modifiers, and excipients. The purity, molecular weight, and degradation rate of polymers determine the drug’s release profile and stability, while lipid materials enhance the bioavailability of lipophilic compounds. Recently, the global supply chain has shifted toward advanced medical-grade materials, fostering the development of safer and more controllable long-acting delivery platforms.

This report aims to provide a comprehensive presentation of the global market for Long-acting Depot System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-acting Depot System.

The Long-acting Depot System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Long-acting Depot System market comprehensively. Regional market sizes, concerning products by Type, by Application, by Drugs Type and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Long-acting Depot System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Long-acting Depot System Market Report

Report Metric	Details
Report Name	Long-acting Depot System Market
Accounted market size in year	US$ 47154 million
Forecasted market size in 2031	US$ 61195 million
CAGR	3.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Tablet Injection
Segment by Drugs Type	Brand Drugs Generic Drugs
Segment by Disease	Central Nervous System Diseases Cardiovascular Diseases Diabetes Cancer Chronic Pain Other
Segment by Application	Hospital Retail Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, AbbVie, Novartis, Recipharm, Alkermes, Bristol‑Myers Squibb, Boehringer Ingelheim, Bayer, SPH, Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, United Laboratory, Biocon, Torrent Pharma, Amphastar, Ganlee, GSK
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Drugs Type etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Long-acting Depot System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Long-acting Depot System Market growing?

Ans: The Long-acting Depot System Market witnessing a CAGR of 3.9% during the forecast period 2025-2031.

What is the Long-acting Depot System Market size in 2031?

Ans: The Long-acting Depot System Market size in 2031 will be US$ 61195 million.

Who are the main players in the Long-acting Depot System Market report?

Ans: The main players in the Long-acting Depot System Market are Pfizer, AbbVie, Novartis, Recipharm, Alkermes, Bristol‑Myers Squibb, Boehringer Ingelheim, Bayer, SPH, Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, United Laboratory, Biocon, Torrent Pharma, Amphastar, Ganlee, GSK

What are the Application segmentation covered in the Long-acting Depot System Market report?

Ans: The Applications covered in the Long-acting Depot System Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Long-acting Depot System Market report?

Ans: The Types covered in the Long-acting Depot System Market report are Brand Drugs, Generic Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Long-acting Depot System Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Tablet

1.2.3 Injection

1.3 Market by Drugs Type

1.3.1 Global Long-acting Depot System Market Size Growth Rate by Drugs Type: 2020 VS 2024 VS 2031

1.3.2 Brand Drugs

1.3.3 Generic Drugs

1.4 Market by Disease

1.4.1 Global Long-acting Depot System Market Size Growth Rate by Disease: 2020 VS 2024 VS 2031

1.4.2 Central Nervous System Diseases

1.4.3 Cardiovascular Diseases

1.4.4 Diabetes

1.4.5 Cancer

1.4.6 Chronic Pain

1.4.7 Other

1.5 Market by Application

1.5.1 Global Long-acting Depot System Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Hospital

1.5.3 Retail Pharmacy

1.5.4 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Long-acting Depot System Market Perspective (2020-2031)

2.2 Global Long-acting Depot System Growth Trends by Region

2.2.1 Global Long-acting Depot System Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Long-acting Depot System Historic Market Size by Region (2020-2025)

2.2.3 Long-acting Depot System Forecasted Market Size by Region (2026-2031)

2.3 Long-acting Depot System Market Dynamics

2.3.1 Long-acting Depot System Industry Trends

2.3.2 Long-acting Depot System Market Drivers

2.3.3 Long-acting Depot System Market Challenges

2.3.4 Long-acting Depot System Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Long-acting Depot System Players by Revenue

3.1.1 Global Top Long-acting Depot System Players by Revenue (2020-2025)

3.1.2 Global Long-acting Depot System Revenue Market Share by Players (2020-2025)

3.2 Global Top Long-acting Depot System Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Long-acting Depot System Revenue

3.4 Global Long-acting Depot System Market Concentration Ratio

3.4.1 Global Long-acting Depot System Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Long-acting Depot System Revenue in 2024

3.5 Global Key Players of Long-acting Depot System Head office and Area Served

3.6 Global Key Players of Long-acting Depot System, Product and Application

3.7 Global Key Players of Long-acting Depot System, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Long-acting Depot System Breakdown Data by Type

4.1 Global Long-acting Depot System Historic Market Size by Type (2020-2025)

4.2 Global Long-acting Depot System Forecasted Market Size by Type (2026-2031)

5 Long-acting Depot System Breakdown Data by Application

5.1 Global Long-acting Depot System Historic Market Size by Application (2020-2025)

5.2 Global Long-acting Depot System Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Long-acting Depot System Market Size (2020-2031)

6.2 North America Long-acting Depot System Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Long-acting Depot System Market Size by Country (2020-2025)

6.4 North America Long-acting Depot System Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Long-acting Depot System Market Size (2020-2031)

7.2 Europe Long-acting Depot System Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Long-acting Depot System Market Size by Country (2020-2025)

7.4 Europe Long-acting Depot System Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Long-acting Depot System Market Size (2020-2031)

8.2 Asia-Pacific Long-acting Depot System Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Long-acting Depot System Market Size by Region (2020-2025)

8.4 Asia-Pacific Long-acting Depot System Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Long-acting Depot System Market Size (2020-2031)

9.2 Latin America Long-acting Depot System Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Long-acting Depot System Market Size by Country (2020-2025)

9.4 Latin America Long-acting Depot System Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Long-acting Depot System Market Size (2020-2031)

10.2 Middle East & Africa Long-acting Depot System Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Long-acting Depot System Market Size by Country (2020-2025)

10.4 Middle East & Africa Long-acting Depot System Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Long-acting Depot System Introduction

11.1.4 Pfizer Revenue in Long-acting Depot System Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 AbbVie

11.2.1 AbbVie Company Details

11.2.2 AbbVie Business Overview

11.2.3 AbbVie Long-acting Depot System Introduction

11.2.4 AbbVie Revenue in Long-acting Depot System Business (2020-2025)

11.2.5 AbbVie Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Long-acting Depot System Introduction

11.3.4 Novartis Revenue in Long-acting Depot System Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Recipharm

11.4.1 Recipharm Company Details

11.4.2 Recipharm Business Overview

11.4.3 Recipharm Long-acting Depot System Introduction

11.4.4 Recipharm Revenue in Long-acting Depot System Business (2020-2025)

11.4.5 Recipharm Recent Development

11.5 Alkermes

11.5.1 Alkermes Company Details

11.5.2 Alkermes Business Overview

11.5.3 Alkermes Long-acting Depot System Introduction

11.5.4 Alkermes Revenue in Long-acting Depot System Business (2020-2025)

11.5.5 Alkermes Recent Development

11.6 Bristol‑Myers Squibb

11.6.1 Bristol‑Myers Squibb Company Details

11.6.2 Bristol‑Myers Squibb Business Overview

11.6.3 Bristol‑Myers Squibb Long-acting Depot System Introduction

11.6.4 Bristol‑Myers Squibb Revenue in Long-acting Depot System Business (2020-2025)

11.6.5 Bristol‑Myers Squibb Recent Development

11.7 Boehringer Ingelheim

11.7.1 Boehringer Ingelheim Company Details

11.7.2 Boehringer Ingelheim Business Overview

11.7.3 Boehringer Ingelheim Long-acting Depot System Introduction

11.7.4 Boehringer Ingelheim Revenue in Long-acting Depot System Business (2020-2025)

11.7.5 Boehringer Ingelheim Recent Development

11.8 Bayer

11.8.1 Bayer Company Details

11.8.2 Bayer Business Overview

11.8.3 Bayer Long-acting Depot System Introduction

11.8.4 Bayer Revenue in Long-acting Depot System Business (2020-2025)

11.8.5 Bayer Recent Development

11.9 SPH

11.9.1 SPH Company Details

11.9.2 SPH Business Overview

11.9.3 SPH Long-acting Depot System Introduction

11.9.4 SPH Revenue in Long-acting Depot System Business (2020-2025)

11.9.5 SPH Recent Development

11.10 Novo Nordisk

11.10.1 Novo Nordisk Company Details

11.10.2 Novo Nordisk Business Overview

11.10.3 Novo Nordisk Long-acting Depot System Introduction

11.10.4 Novo Nordisk Revenue in Long-acting Depot System Business (2020-2025)

11.10.5 Novo Nordisk Recent Development

11.11 Sanofi-Aventis

11.11.1 Sanofi-Aventis Company Details

11.11.2 Sanofi-Aventis Business Overview

11.11.3 Sanofi-Aventis Long-acting Depot System Introduction

11.11.4 Sanofi-Aventis Revenue in Long-acting Depot System Business (2020-2025)

11.11.5 Sanofi-Aventis Recent Development

11.12 Eli Lilly

11.12.1 Eli Lilly Company Details

11.12.2 Eli Lilly Business Overview

11.12.3 Eli Lilly Long-acting Depot System Introduction

11.12.4 Eli Lilly Revenue in Long-acting Depot System Business (2020-2025)

11.12.5 Eli Lilly Recent Development

11.13 Tonghua Dongbao

11.13.1 Tonghua Dongbao Company Details

11.13.2 Tonghua Dongbao Business Overview

11.13.3 Tonghua Dongbao Long-acting Depot System Introduction

11.13.4 Tonghua Dongbao Revenue in Long-acting Depot System Business (2020-2025)

11.13.5 Tonghua Dongbao Recent Development

11.14 United Laboratory

11.14.1 United Laboratory Company Details

11.14.2 United Laboratory Business Overview

11.14.3 United Laboratory Long-acting Depot System Introduction

11.14.4 United Laboratory Revenue in Long-acting Depot System Business (2020-2025)

11.14.5 United Laboratory Recent Development

11.15 Biocon

11.15.1 Biocon Company Details

11.15.2 Biocon Business Overview

11.15.3 Biocon Long-acting Depot System Introduction

11.15.4 Biocon Revenue in Long-acting Depot System Business (2020-2025)

11.15.5 Biocon Recent Development

11.16 Torrent Pharma

11.16.1 Torrent Pharma Company Details

11.16.2 Torrent Pharma Business Overview

11.16.3 Torrent Pharma Long-acting Depot System Introduction

11.16.4 Torrent Pharma Revenue in Long-acting Depot System Business (2020-2025)

11.16.5 Torrent Pharma Recent Development

11.17 Amphastar

11.17.1 Amphastar Company Details

11.17.2 Amphastar Business Overview

11.17.3 Amphastar Long-acting Depot System Introduction

11.17.4 Amphastar Revenue in Long-acting Depot System Business (2020-2025)

11.17.5 Amphastar Recent Development

11.18 Ganlee

11.18.1 Ganlee Company Details

11.18.2 Ganlee Business Overview

11.18.3 Ganlee Long-acting Depot System Introduction

11.18.4 Ganlee Revenue in Long-acting Depot System Business (2020-2025)

11.18.5 Ganlee Recent Development

11.19 GSK

11.19.1 GSK Company Details

11.19.2 GSK Business Overview

11.19.3 GSK Long-acting Depot System Introduction

11.19.4 GSK Revenue in Long-acting Depot System Business (2020-2025)

11.19.5 GSK Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Long-acting Depot System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Tablet

Table 3. Key Players of Injection

Table 4. Global Long-acting Depot System Market Size Growth Rate by Drugs Type (US$ Million): 2020 VS 2024 VS 2031

Table 5. Key Players of Brand Drugs

Table 6. Key Players of Generic Drugs

Table 7. Global Long-acting Depot System Market Size Growth Rate by Disease (US$ Million): 2020 VS 2024 VS 2031

Table 8. Key Players of Central Nervous System Diseases

Table 9. Key Players of Cardiovascular Diseases

Table 10. Key Players of Diabetes

Table 11. Key Players of Cancer

Table 12. Key Players of Chronic Pain

Table 13. Key Players of Other

Table 14. Global Long-acting Depot System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 15. Global Long-acting Depot System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 16. Global Long-acting Depot System Market Size by Region (2020-2025) & (US$ Million)

Table 17. Global Long-acting Depot System Market Share by Region (2020-2025)

Table 18. Global Long-acting Depot System Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 19. Global Long-acting Depot System Market Share by Region (2026-2031)

Table 20. Long-acting Depot System Market Trends

Table 21. Long-acting Depot System Market Drivers

Table 22. Long-acting Depot System Market Challenges

Table 23. Long-acting Depot System Market Restraints

Table 24. Global Long-acting Depot System Revenue by Players (2020-2025) & (US$ Million)

Table 25. Global Long-acting Depot System Market Share by Players (2020-2025)

Table 26. Global Top Long-acting Depot System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Depot System as of 2024)

Table 27. Ranking of Global Top Long-acting Depot System Companies by Revenue (US$ Million) in 2024

Table 28. Global 5 Largest Players Market Share by Long-acting Depot System Revenue (CR5 and HHI) & (2020-2025)

Table 29. Global Key Players of Long-acting Depot System, Headquarters and Area Served

Table 30. Global Key Players of Long-acting Depot System, Product and Application

Table 31. Global Key Players of Long-acting Depot System, Date of Enter into This Industry

Table 32. Mergers & Acquisitions, Expansion Plans

Table 33. Global Long-acting Depot System Market Size by Type (2020-2025) & (US$ Million)

Table 34. Global Long-acting Depot System Revenue Market Share by Type (2020-2025)

Table 35. Global Long-acting Depot System Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 36. Global Long-acting Depot System Revenue Market Share by Type (2026-2031)

Table 37. Global Long-acting Depot System Market Size by Application (2020-2025) & (US$ Million)

Table 38. Global Long-acting Depot System Revenue Market Share by Application (2020-2025)

Table 39. Global Long-acting Depot System Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 40. Global Long-acting Depot System Revenue Market Share by Application (2026-2031)

Table 41. North America Long-acting Depot System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. North America Long-acting Depot System Market Size by Country (2020-2025) & (US$ Million)

Table 43. North America Long-acting Depot System Market Size by Country (2026-2031) & (US$ Million)

Table 44. Europe Long-acting Depot System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Europe Long-acting Depot System Market Size by Country (2020-2025) & (US$ Million)

Table 46. Europe Long-acting Depot System Market Size by Country (2026-2031) & (US$ Million)

Table 47. Asia-Pacific Long-acting Depot System Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 48. Asia-Pacific Long-acting Depot System Market Size by Region (2020-2025) & (US$ Million)

Table 49. Asia-Pacific Long-acting Depot System Market Size by Region (2026-2031) & (US$ Million)

Table 50. Latin America Long-acting Depot System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 51. Latin America Long-acting Depot System Market Size by Country (2020-2025) & (US$ Million)

Table 52. Latin America Long-acting Depot System Market Size by Country (2026-2031) & (US$ Million)

Table 53. Middle East & Africa Long-acting Depot System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 54. Middle East & Africa Long-acting Depot System Market Size by Country (2020-2025) & (US$ Million)

Table 55. Middle East & Africa Long-acting Depot System Market Size by Country (2026-2031) & (US$ Million)

Table 56. Pfizer Company Details

Table 57. Pfizer Business Overview

Table 58. Pfizer Long-acting Depot System Product

Table 59. Pfizer Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 60. Pfizer Recent Development

Table 61. AbbVie Company Details

Table 62. AbbVie Business Overview

Table 63. AbbVie Long-acting Depot System Product

Table 64. AbbVie Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 65. AbbVie Recent Development

Table 66. Novartis Company Details

Table 67. Novartis Business Overview

Table 68. Novartis Long-acting Depot System Product

Table 69. Novartis Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 70. Novartis Recent Development

Table 71. Recipharm Company Details

Table 72. Recipharm Business Overview

Table 73. Recipharm Long-acting Depot System Product

Table 74. Recipharm Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 75. Recipharm Recent Development

Table 76. Alkermes Company Details

Table 77. Alkermes Business Overview

Table 78. Alkermes Long-acting Depot System Product

Table 79. Alkermes Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 80. Alkermes Recent Development

Table 81. Bristol‑Myers Squibb Company Details

Table 82. Bristol‑Myers Squibb Business Overview

Table 83. Bristol‑Myers Squibb Long-acting Depot System Product

Table 84. Bristol‑Myers Squibb Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 85. Bristol‑Myers Squibb Recent Development

Table 86. Boehringer Ingelheim Company Details

Table 87. Boehringer Ingelheim Business Overview

Table 88. Boehringer Ingelheim Long-acting Depot System Product

Table 89. Boehringer Ingelheim Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 90. Boehringer Ingelheim Recent Development

Table 91. Bayer Company Details

Table 92. Bayer Business Overview

Table 93. Bayer Long-acting Depot System Product

Table 94. Bayer Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 95. Bayer Recent Development

Table 96. SPH Company Details

Table 97. SPH Business Overview

Table 98. SPH Long-acting Depot System Product

Table 99. SPH Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 100. SPH Recent Development

Table 101. Novo Nordisk Company Details

Table 102. Novo Nordisk Business Overview

Table 103. Novo Nordisk Long-acting Depot System Product

Table 104. Novo Nordisk Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 105. Novo Nordisk Recent Development

Table 106. Sanofi-Aventis Company Details

Table 107. Sanofi-Aventis Business Overview

Table 108. Sanofi-Aventis Long-acting Depot System Product

Table 109. Sanofi-Aventis Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 110. Sanofi-Aventis Recent Development

Table 111. Eli Lilly Company Details

Table 112. Eli Lilly Business Overview

Table 113. Eli Lilly Long-acting Depot System Product

Table 114. Eli Lilly Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 115. Eli Lilly Recent Development

Table 116. Tonghua Dongbao Company Details

Table 117. Tonghua Dongbao Business Overview

Table 118. Tonghua Dongbao Long-acting Depot System Product

Table 119. Tonghua Dongbao Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 120. Tonghua Dongbao Recent Development

Table 121. United Laboratory Company Details

Table 122. United Laboratory Business Overview

Table 123. United Laboratory Long-acting Depot System Product

Table 124. United Laboratory Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 125. United Laboratory Recent Development

Table 126. Biocon Company Details

Table 127. Biocon Business Overview

Table 128. Biocon Long-acting Depot System Product

Table 129. Biocon Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 130. Biocon Recent Development

Table 131. Torrent Pharma Company Details

Table 132. Torrent Pharma Business Overview

Table 133. Torrent Pharma Long-acting Depot System Product

Table 134. Torrent Pharma Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 135. Torrent Pharma Recent Development

Table 136. Amphastar Company Details

Table 137. Amphastar Business Overview

Table 138. Amphastar Long-acting Depot System Product

Table 139. Amphastar Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 140. Amphastar Recent Development

Table 141. Ganlee Company Details

Table 142. Ganlee Business Overview

Table 143. Ganlee Long-acting Depot System Product

Table 144. Ganlee Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 145. Ganlee Recent Development

Table 146. GSK Company Details

Table 147. GSK Business Overview

Table 148. GSK Long-acting Depot System Product

Table 149. GSK Revenue in Long-acting Depot System Business (2020-2025) & (US$ Million)

Table 150. GSK Recent Development

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

Table 154. Authors List of This Report

List of Figures

Figure 1. Long-acting Depot System Picture

Figure 2. Global Long-acting Depot System Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Long-acting Depot System Market Share by Type: 2024 VS 2031

Figure 4. Tablet Features

Figure 5. Injection Features

Figure 6. Global Long-acting Depot System Market Size Comparison by Drugs Type (2020-2031) & (US$ Million)

Figure 7. Brand Drugs Features

Figure 8. Generic Drugs Features

Figure 9. Global Long-acting Depot System Market Size Comparison by Disease (2020-2031) & (US$ Million)

Figure 10. Central Nervous System Diseases Features

Figure 11. Cardiovascular Diseases Features

Figure 12. Diabetes Features

Figure 13. Cancer Features

Figure 14. Chronic Pain Features

Figure 15. Other Features

Figure 16. Global Long-acting Depot System Market Size by Application (2020-2031) & (US$ Million)

Figure 17. Global Long-acting Depot System Market Share by Application: 2024 VS 2031

Figure 18. Hospital Case Studies

Figure 19. Retail Pharmacy Case Studies

Figure 20. Other Case Studies

Figure 21. Long-acting Depot System Report Years Considered

Figure 22. Global Long-acting Depot System Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 23. Global Long-acting Depot System Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 24. Global Long-acting Depot System Market Share by Region: 2024 VS 2031

Figure 25. Global Long-acting Depot System Market Share by Players in 2024

Figure 26. Global Long-acting Depot System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 27. The Top 10 and 5 Players Market Share by Long-acting Depot System Revenue in 2024

Figure 28. North America Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. North America Long-acting Depot System Market Share by Country (2020-2031)

Figure 30. United States Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Canada Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Europe Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Europe Long-acting Depot System Market Share by Country (2020-2031)

Figure 34. Germany Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. France Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. U.K. Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Italy Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Russia Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Ireland Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Asia-Pacific Long-acting Depot System Market Share by Region (2020-2031)

Figure 42. China Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Japan Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. South Korea Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. India Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Australia & New Zealand Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Latin America Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Latin America Long-acting Depot System Market Share by Country (2020-2031)

Figure 50. Mexico Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Brazil Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Middle East & Africa Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Middle East & Africa Long-acting Depot System Market Share by Country (2020-2031)

Figure 54. Israel Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. UAE Long-acting Depot System Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Pfizer Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 58. AbbVie Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 59. Novartis Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 60. Recipharm Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 61. Alkermes Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 62. Bristol‑Myers Squibb Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 63. Boehringer Ingelheim Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 64. Bayer Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 65. SPH Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 66. Novo Nordisk Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 67. Sanofi-Aventis Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 68. Eli Lilly Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 69. Tonghua Dongbao Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 70. United Laboratory Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 71. Biocon Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 72. Torrent Pharma Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 73. Amphastar Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 74. Ganlee Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 75. GSK Revenue Growth Rate in Long-acting Depot System Business (2020-2025)

Figure 76. Bottom-up and Top-down Approaches for This Report

Figure 77. Data Triangulation

Figure 78. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Drug Taste Masking Technologies Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28J19891

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Organoids LNP Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4L20275

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Cellular Residual Interleukin Detection Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-20V20315

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Pyoderma Gangrenosum Therapeutics Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5N20105

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions